These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6671459)

  • 21. The physicochemical nature and biological function of extrapancreatic immunoreactive glucagon.
    Ikei S; Mori K; Sakamoto Y; Ishii J; Watanabe O; Inoue M; Akagi M
    Gastroenterol Jpn; 1980; 15(3):241-6. PubMed ID: 7399222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding and degradation of 125I-glucagon by highly purified rat liver plasma membranes.
    Balage M; Grizard J; Grizard G
    Biochim Biophys Acta; 1986 Oct; 884(1):101-8. PubMed ID: 3768403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin G can cross-react with glucagon antisera and cause a spuriously high plasma immunoreactive glucagon level.
    Hattori N; Saiki Y; Kajikawa M; Ishihara T; Moridera K; Hino M; Ikekubo K; Kurahachi H
    Endocr J; 1995 Aug; 42(4):455-60. PubMed ID: 8556050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cysteamine and antibody to somatostatin on islet cell function in vitro. Evidence that intracellular somatostatin deficiency augments insulin and glucagon secretion.
    Patel YC; Pierzchala I; Amherdt M; Orci L
    J Clin Invest; 1985 Apr; 75(4):1249-55. PubMed ID: 2859301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dominant inheritance of large molecular weight immunoreactive glucagon.
    Palmer JP; Werner PL; Benson JW; Ensinck JW
    J Clin Invest; 1978 Mar; 61(3):763-9. PubMed ID: 641153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased "large glucagon-immunoreactivity".
    Recant L; Perrino PV; Bhathena SJ; Danforth DN; Lavine RL
    Diabetologia; 1976 Aug; 12(4):319-26. PubMed ID: 183997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma glucagon immunoreactivity in a totally pancreatectomized patient.
    Villanueva ML; Hedo JA; Marco J
    Diabetologia; 1976 Dec; 12(6):613-6. PubMed ID: 1001850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of extrapancreatic immunoreactive glucagon to intraluminal nutrients in pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Jul; 16(7):344-8. PubMed ID: 6386643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon-degrading activity in acid-ethanol extract of rat submandibular gland.
    Tahara Y; Shima K; Hirota M; Tanaka A; Ikegami H; Yamamoto Y; Fukuda M; Kumahara Y
    Horm Metab Res; 1986 Dec; 18(12):800-3. PubMed ID: 3817745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucagon immunoreactivity and chromatographic profiles in pancreatectomized humans. Paradoxical response to oral glucose.
    Bajorunas DR; Fortner JG; Jaspan JB
    Diabetes; 1986 Aug; 35(8):886-93. PubMed ID: 3525286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the control of glucagon secretion by the parasympathetic nervous system in man.
    Palmer JP; Werner PL; Hollander P; Ensinck JW
    Metabolism; 1979 May; 28(5):549-52. PubMed ID: 449696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The serum glucose response to glucagon suppression with somatostatin, insulin or antiglucagon serum in depancreatized rats.
    Dunbar JC; Walsh MF; Foà PP
    Diabetologia; 1978 Jan; 14(1):53-8. PubMed ID: 627333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of immunoreactive insulin, glucagon and pancreatic polypeptide in the plasma of depancreatized chickens.
    Colca JR; Hazelwood RL
    J Endocrinol; 1982 Mar; 92(3):317-26. PubMed ID: 7040582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degradation of glucagon in isolated liver endosomes. ATP-dependence and partial characterization of degradation products.
    Authier F; Desbuquois B
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):211-8. PubMed ID: 1741749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fate of injected glucagon taken up by rat liver in vivo. Degradation of internalized ligand in the endosomal compartment.
    Authier F; Janicot M; Lederer F; Desbuquois B
    Biochem J; 1990 Dec; 272(3):703-12. PubMed ID: 2268296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reinvestigation of the radioimmunoassay for plasma glucagon. Effect of glucagon-degrading activity in rat plasma on immunoreactive glucagon values].
    Miyazaki H
    Fukuoka Igaku Zasshi; 1988 Jan; 79(1):24-37. PubMed ID: 2838405
    [No Abstract]   [Full Text] [Related]  

  • 37. Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes.
    Kuku SF; Zeidler A; Emmanouel DS; Katz AI; Rubenstein AH
    J Clin Endocrinol Metab; 1976 Jan; 42(1):173-6. PubMed ID: 1249185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxytocin stimulates glucagon and insulin secretion in fetal and neonatal sheep.
    Wallin LA; Fawcett CP; Rosenfeld CR
    Endocrinology; 1989 Nov; 125(5):2289-96. PubMed ID: 2676481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretion and degradation of insulin and glucagon in carbon tetrachloride-induced liver injury rats.
    Ikeda T; Takeuchi T; Ito Y; Murakami I; Mokuda O; Tominaga M; Mashiba H
    Am J Physiol; 1986 Dec; 251(6 Pt 1):E660-3. PubMed ID: 3538899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoreactive glucagon in the smooth muscle cells of the rat cerebral artery: an immunohistochemical analysis.
    Matsuyama T; Shiosaka S; Matsumoto M; Mieno M; Yoneda S; Kimura K; Hayashi N; Kamada T; Abe H; Hayakawa T
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):305-7. PubMed ID: 6725442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.